Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kung

Showing results (241-250 of 378) with videos related to

Pageof 38
Sort By:
Angiogenesis|January 22, 2013
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosisHui Xu, Tao Zhang, Gene Chi Wai Man, et al.
Cancer Cell|November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemiasAndrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
Blood|May 11, 2011
Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesisStephanie N Zimmer, Qing Zhou, Ting Zhou, et al.
The Journal of Experimental Medicine|August 3, 2011
High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signalingHind Medyouf, Samuel Gusscott, Hongfang Wang, et al.
Chemistry & Biology|August 2, 2011
A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivoJames J Cronican, Kevin T Beier, Tina N Davis, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Blood|January 11, 2008
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cellsEllen Weisberg, Lolita Banerji, Renee D Wright, et al.
Molecular Cancer Therapeutics|October 10, 2019
Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade GliomaJohn A DeSisto, Patrick Flannery, Rakeb Lemma, et al.
Cancer Cell|July 12, 2011
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1LKathrin M Bernt, Nan Zhu, Amit U Sinha, et al.
Molecular Cancer Therapeutics|July 11, 2007
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cellsEllen Weisberg, Andrew L Kung, Renee D Wright, et al.
Pageof 38

Showing results (241-250 of 378) with videos related to

Sort By:
Pageof 38
Angiogenesis|January 22, 2013
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosisHui Xu, Tao Zhang, Gene Chi Wai Man, et al.
Cancer Cell|November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemiasAndrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
Blood|May 11, 2011
Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesisStephanie N Zimmer, Qing Zhou, Ting Zhou, et al.
The Journal of Experimental Medicine|August 3, 2011
High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signalingHind Medyouf, Samuel Gusscott, Hongfang Wang, et al.
Chemistry & Biology|August 2, 2011
A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivoJames J Cronican, Kevin T Beier, Tina N Davis, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Blood|January 11, 2008
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cellsEllen Weisberg, Lolita Banerji, Renee D Wright, et al.
Molecular Cancer Therapeutics|October 10, 2019
Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade GliomaJohn A DeSisto, Patrick Flannery, Rakeb Lemma, et al.
Cancer Cell|July 12, 2011
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1LKathrin M Bernt, Nan Zhu, Amit U Sinha, et al.
Molecular Cancer Therapeutics|July 11, 2007
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cellsEllen Weisberg, Andrew L Kung, Renee D Wright, et al.
Pageof 38